Skip Nav Destination
Article navigation
1 June 2022
Research Watch|
June 02 2022
CAR T Cells with a Dominant-Negative TGFβ Receptor Are Safe and Feasible
Online Issn: 2159-8290
Print Issn: 2159-8274
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
Cancer Discov (2022) 12 (6): 1406.
- Views Icon Views
- Share Icon Share
-
Tools Icon
Tools
- Search Site
-
Article Versions Icon
Versions
- Version of Record June 2 2022
- Proof April 1 2022
Citation
CAR T Cells with a Dominant-Negative TGFβ Receptor Are Safe and Feasible. Cancer Discov 1 June 2022; 12 (6): 1406. https://doi.org/10.1158/2159-8290.CD-RW2022-057
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionPay-Per-View Access
$50.00
171
Views
0
Citations
Citing articles via
Advertisement